Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors

The Journal of Family Practice. 2017 February;66(2):
A supplement to The Journal of Family Practice. This supplement is sponsored by Primary Care Education Consortium and Primary Care Metabolic Group and supported by funding from Janssen Pharmaceuticals, Inc.
January 26, 2017|The Journal of Family Practice
This supplement highlights the efficacy and safety of using SGLT-2 inhibitors in the individualized treatment of type 2 diabetes.
 

Faculty/Faculty Disclosure

Eden M. Miller, DO

Executive Director and Co-founder, Diabetes Nation

,

High Lakes Health Care

St. Charles Hospital

Bend, Oregon

Competing Interest and Financial Disclosures: Dr. Miller discloses that she is on the advisory boards and speakers’ bureaus for AstraZeneca, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc.

Click here to view the PDF.